Welgene Biotech Co.,Ltd. (6661.TWO)

TWD 19.7

(2.6%)

Revenue Summary of Welgene Biotech Co.,Ltd.

Welgene Biotech Co.,Ltd.'s latest annual revenue in 2023 was 280.54 Million TWD , down -12.85% from previous year.
Welgene Biotech Co.,Ltd.'s latest quarterly revenue in 2024 Q2 was 76 Million TWD , up 11.09% from previous quarter.
Welgene Biotech Co.,Ltd. reported a annual revenue of 321.89 Million TWD in annual revenue 2022, up 2.96% from previous year.
Welgene Biotech Co.,Ltd. reported a annual revenue of 312.65 Million TWD in annual revenue 2021, down -21.46% from previous year.
Welgene Biotech Co.,Ltd. reported a quarterly revenue of 68.42 Million TWD for 2024 Q1, down -7.11% from previous quarter.
Welgene Biotech Co.,Ltd. reported a quarterly revenue of 73.65 Million TWD for 2023 Q4, down -8.42% from previous quarter.

Annual Revenue Chart of Welgene Biotech Co.,Ltd. (2023 - 2014)

Historical Annual Revenue of Welgene Biotech Co.,Ltd. (2023 - 2014)

Year	Revenue	Revenue Growth
2023	280.54 Million TWD	-12.85%
2022	321.89 Million TWD	2.96%
2021	312.65 Million TWD	-21.46%
2020	398.09 Million TWD	-4.64%
2019	417.45 Million TWD	8.59%
2018	384.42 Million TWD	18.0%
2017	325.77 Million TWD	17.06%
2016	278.29 Million TWD	0.32%
2015	277.4 Million TWD	2.67%
2014	270.17 Million TWD	0.0%

Year	Revenue	Revenue Growth
2024 Q2	76 Million TWD	11.09%
2024 Q1	68.42 Million TWD	-7.11%
2023 Q4	73.65 Million TWD	-8.42%
2023 FY	280.54 Million TWD	-12.85%
2023 Q1	49.13 Million TWD	-32.03%
2023 Q2	77.33 Million TWD	57.4%
2023 Q3	80.42 Million TWD	4.0%
2022 Q2	105.46 Million TWD	46.57%
2022 Q4	72.28 Million TWD	0.11%
2022 Q3	72.2 Million TWD	-31.54%
2022 Q1	71.95 Million TWD	-32.25%
2022 FY	321.89 Million TWD	2.96%
2021 Q3	82.62 Million TWD	9.42%
2021 FY	312.65 Million TWD	-21.46%
2021 Q4	106.2 Million TWD	28.54%
2021 Q1	48.31 Million TWD	-54.32%
2021 Q2	75.51 Million TWD	56.31%
2020 FY	398.09 Million TWD	-4.64%
2020 Q4	105.75 Million TWD	6.85%
2020 Q3	98.97 Million TWD	-2.58%
2020 Q2	101.59 Million TWD	10.71%
2020 Q1	91.76 Million TWD	-29.91%
2019 FY	417.45 Million TWD	8.59%
2019 Q4	130.91 Million TWD	3.42%
2019 Q3	126.58 Million TWD	58.27%
2019 Q2	79.97 Million TWD	0.0%
2019 Q1	79.97 Million TWD	-23.99%
2018 Q2	86.99 Million TWD	0.0%
2018 FY	384.42 Million TWD	18.0%
2018 Q1	86.99 Million TWD	-0.27%
2018 Q3	105.22 Million TWD	20.95%
2018 Q4	105.22 Million TWD	0.0%
2017 Q3	87.22 Million TWD	15.29%
2017 Q2	75.65 Million TWD	0.0%
2017 Q4	87.22 Million TWD	0.0%
2017 FY	325.77 Million TWD	17.06%
2017 Q1	75.65 Million TWD	3.21%
2016 FY	278.29 Million TWD	0.32%
2016 Q4	73.3 Million TWD	0.0%
2016 Q3	73.3 Million TWD	11.33%
2016 Q2	65.84 Million TWD	0.0%
2016 Q1	65.84 Million TWD	0.0%
2015 FY	277.4 Million TWD	2.67%
2014 FY	270.17 Million TWD	0.0%

Peer Revenue Comparison of Welgene Biotech Co.,Ltd.

Name	Revenue	Revenue Difference
BIONET Corp.	1.12 Billion TWD	75.113%
DIVA Laboratories, Ltd.	893.84 Million TWD	68.613%
Genetics Generation Advancement Corp.	592.5 Million TWD	52.65%
Puriblood Medical Co., Ltd.	125.26 Million TWD	-123.957%
TFBS Bioscience Inc.	231.91 Million TWD	-20.969%